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Abstract
This randomized study measured the influence of vitamin C (N=15) compared to placebo (N=13) 
supplementation on oxidative and salivary immunoglobulin A (sIgA) changes in runners competing in an 
ultramarathon race. Seven days prior to the race, subjects ingested in randomized, double-blind fashion three 
500-mg tablets of vitamin C or placebo each day. On race day, blood and saliva samples were collected 1 h 
pre-race, after 32 km of running, and then again immediately post-race. During the race, runners received 1 l/h 
carbohydrate beverages (60 g/l) with vitamin C (150 mg/l) or without in a double-blinded fashion. The runners 
also ingested two to three carbohydrate gel packs per hour (25 g each). Subjects in both groups ran a mean of 
69 km (range 48–80 km) in 9.8 h (range 5–12 h) and maintained an intensity of approximately 75% maximal 
heart rate (HRmax) throughout the ultramarathon race. Plasma ascorbic acid was higher in the vitamin C 
compared to placebo group pre-race, and increased significantly in the vitamin C group during the race [post-
race, 3.21 (0.29) and 1.28 (0.12) µg/100 µl, respectively, P<0.001]. No significant group or interaction effects 
were measured for lipid hydroperoxide and F2-isoprostane, but both oxidative measures rose significantly 
during the ultramarathon race. Saliva volume, sIgA concentration, sIgA secretion and sIgA:saliva protein ratio all 
decreased significantly (P<0.001) during the race, but the pattern of change in all saliva measures did not 
differ significantly between groups. No significant correlations were found between post-race plasma vitamin C, 
oxidative, and saliva measures, except for a positive correlation between post-race serum cortisol and serum 
vitamin C (r=0.50, P=0.006). These data indicate that vitamin C supplementation in carbohydrate-fed runners 
does not serve as a countermeasure to oxidative and sIgA changes during or following a competitive 
ultramarathon race.
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Abstract This randomized study measured the influence
of vitamin C (N=15) compared to placebo (N=13)
supplementation on oxidative and salivary immuno-
globulin A (sIgA) changes in runners competing in an
ultramarathon race. Seven days prior to the race, sub-
jects ingested in randomized, double-blind fashion three
500-mg tablets of vitamin C or placebo each day. On
race day, blood and saliva samples were collected 1 h
pre-race, after 32 km of running, and then again im-
mediately post-race. During the race, runners received
1 l/h carbohydrate beverages (60 g/l) with vitamin C
(150 mg/l) or without in a double-blinded fashion. The
runners also ingested two to three carbohydrate gel
packs per hour (25 g each). Subjects in both groups ran
a mean of 69 km (range 48–80 km) in 9.8 h (range 5–
12 h) and maintained an intensity of approximately 75%
maximal heart rate (HRmax) throughout the ultramara-
thon race. Plasma ascorbic acid was higher in the vita-
min C compared to placebo group pre-race, and
increased significantly in the vitamin C group during the
race [post-race, 3.21 (0.29) and 1.28 (0.12) lg/100 ll,
respectively, P<0.001]. No significant group or inter-
action effects were measured for lipid hydroperoxide and
F2-isoprostane, but both oxidative measures rose sig-
nificantly during the ultramarathon race. Saliva volume,
sIgA concentration, sIgA secretion and sIgA:saliva
protein ratio all decreased significantly (P<0.001) dur-
ing the race, but the pattern of change in all saliva
measures did not differ significantly between groups. No
significant correlations were found between post-race
plasma vitamin C, oxidative, and saliva measures, except
for a positive correlation between post-race serum cor-
tisol and serum vitamin C (r=0.50, P=0.006). These
data indicate that vitamin C supplementation in carbo-
hydrate-fed runners does not serve as a countermeasure
to oxidative and sIgA changes during or following a
competitive ultramarathon race.
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Introduction
VitaminC (ascorbic acid) is awater-soluble vitamin found
in the cytosol of cells and in the extracellular fluid. The
benefits of vitamin C as a potential influence on host de-
fense mechanisms and the immune system has generated
great interest (Grimble 1997; Hughes 1999). The immune
system is sensitive to the level of vitamin C intake, and
supplementation of this nutrient alters many aspects of
the human immune response (Anderson et al. 1980;
Campbell et al. 1999; Jacob andBurri 1996). For example,
Tanaka et al. (1994) reported that ascorbic acid deriva-
tives in a culture of human peripheral blood lymphocytes
acted as an immunostimulator of antibody production.
Vitamin C also provides antioxidant protection as an
aqueous phase peroxyl and oxygen radical scavenger and
is concentrated in tissues and fluids with a high potential
for radical generation (Jacob and Burri 1996).
Secretory immunoglobulins found on mucosal sur-
faces play a role in protection against microbial infection
(Nieman and Nehlsen-Cannarella 1991). Saliva is a mu-
cosal secretion that contains the immunoglobulin IgA.
Although it has been proposed that vitamin C may in-
crease salivary IgA (sIgA) values, this has not been
confirmed in a study of healthy subjects (Anderson and
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VanWyk 1980). Heavy physical exertion suppresses sIgA
(Gleeson 2000). The physiologic stress of prolonged, in-
tense endurance exercise may be an appropriate condi-
tion to study the influence of vitamin C on sIgA.
Both sIgA concentration and secretion rate decrease
following endurance exercise longer than 90 min in du-
ration. Tomasi et al. (1982) were the first to report this in a
study of elite cross-country skiers competing in 20- to 50-
km races. Mackinnon et al. (1987) studied elite cyclists
following 2 h of cycling at 90% of anaerobic threshold.
They reported decreased sIgA concentration in both
trained and untrained cyclists after exercise. Müns et al.
(1989) observed a significant decrease in sIgA concen-
tration in threemales following a 31-km race. Steerenberg
et al. (1997) demonstrated that salivary flow rate and total
sIgA output, but not sIgA concentration, were reduced in
42 triathletes following an Olympic-distance triathlon
race event in the Netherlands. The majority of the re-
search indicates that the combination of high-intensity
and prolonged-duration exercise is necessary before sig-
nificant decreases in this immune parameter are detected
(Mackinnon 1996). Few studies have investigated the
influence of vitamin C on immune responses following
intense endurance exercise. Vitamin C is highly concen-
trated in the adrenal cortex, and it has been hypothesized
that vitamin C supplements may influence serum cortisol
release and alterations in immune function following
heavy exertion (Enwonwu et al. 1995;Kodama et al. 1994;
Laney et al. 1990; Redmann et al.1995). In some animal
models, vitamin C depletion has been associated with a
significant increase in serum cortisol without an increase
in adrenocorticotrophic hormone (ACTH) (Enwonwu et
al. 1995; Redmann et al. 1995). In contrast, others have
shown that vitamin C infusion enhances adrenal gluco-
corticoid production (Kodama et al. 1994) or has no effect
on the serum cortisol response to ACTH (Cupps and
Fauci 1982). Two studies involving ultramarathon
runners have supported the hypothesis that vitamin C
influences cortisol release (Nieman et al. 2000; Peters et al.
2001).However, these resultsmay be spurious because the
subjects in these two studies were not randomized to
treatment groups, and carbohydrate intake was not
controlled. It is not known whether vitamin C supple-
mentation may affect post-exercise changes in sIgA
through its influence on cortisol.
The production of reactive oxygen species (ROS)
during exhaustive exercise is well established (Ashton
et al. 1999; Niess et al. 2000; Sanchez-Quesada et al. 1998;
Sen andRoy 2001;White at al. 2001). Several studies have
indicated that vitamin C supplementation attenuates
exercise-induced oxidative stress, but this is not a consis-
tent finding (Ashton et al. 1999; Piercy et al. 2000;
Rokitzki et al. 1994; Sanchez-Quesada et al. 1998;
Thompson et al. 2001;White et al. 2001). ROS generation
and antioxidant status may be linked to immune
alterations following exercise, such as cell adhesion,
inflammation, and lymphocyte proliferation. Conversely,
certain immune changes may contribute to oxidative
stress (Chen et al. 1998; Niess at al. 2000; Sen and Roy
2001; Vider et al. 2001). No data are currently available
regarding how oxidative changes may influence the pro-
duction of sIgA, although antioxidants such as vitamin C
do play a role in preventing damage to immune cells
(Hughes 1999).
The purpose of this study was to examine the influ-
ence of vitamin C compared to placebo supplementation
on oxidative and sIgA changes in ultramarathoners
following an 80-km race. To improve upon previous
studies, subjects were randomized to treatment groups,
and carbohydrate intake was carefully monitored. Other
immune data from this study have been published else-
where (Nieman et al. 2002).
Methods
Subjects
Ultramarathon runners were recruited through a letter of invitation
prior to the April 7, 2001, Umstead Ultramarathon, in Raleigh,
North Carolina. The Umstead Ultramarathon is conducted on a
16-km loop, which is run five times for the 80-km race. Male and
female runners ranging in age from 20 to 70 years were accepted
into the study if they had run at least one competitive ultramara-
thon, had trained and were capable of completing an 80-km race,
and were willing to adhere to all aspects of the research design
including randomized selection to either the vitamin C or placebo
group. Informed consent was obtained from each subject, and the
experimental procedures were in accordance with the policy state-
ments of the institutional review board of Appalachian State
University (ASU).
Research design
Four to six weeks prior to the ultramarathon race event, subjects
reported to the ASU Human Performance Lab for orientation and
measurement of body composition and cardiorespiratory fitness.
Basic demographic and training data were obtained through a
questionnaire. Runners agreed to avoid the use of large-dose vi-
tamin/mineral supplements (above 100% of recommended dietary
allowances), herbs, and medications, known to affect immune
function, for 1 month prior to the race. Runners also agreed to
avoid ingesting anti-inflammatory medications the day before or
during the race. During orientation, a dietitian instructed the
runners to follow a diet high in carbohydrate and moderate in
vitamin C during the 7 days prior to the race event (through use of
a food list) and to record dietary intake using a 7-day food record.
Body composition was assessed utilizing hydrostatic weighing,
and maximal oxygen consumption ( _V O2max) was determined using
a graded maximal protocol adapted for runners as described in
earlier studies from our group (Nieman 2000; Nieman et al. 1997,
1998, 2001b). Oxygen uptake and ventilation were measured using
the MedGraphics CPX metabolic system (MedGraphics, St. Paul,
Mn., USA). Maximal heart rate (HRmax) was measured using a
chest heart rate monitor (Polar Electro, Woodbury, N.Y., USA).
Subjects were randomized to vitamin C or placebo groups.
During the 7-day period prior to the race, subjects ingested three
500-mg tablets of vitamin C or placebo each day (one at each
meal). All tablets were administered in a double-blinded fashion,
and compliance was verified with post-study surveys. Other than
the carbohydrate beverage supplied by the research team, subjects
avoided food or beverages containing calories or caffeine for 6 h
prior to the race start.
On race day, 29 ultramarathon runners reported to the start
area between 4:30 and 5:00 a.m. After sitting for 10–15 min, blood
and saliva samples were collected. Subjects were weighed, and a
chest heart rate monitor was attached to each runner. Runners
received carbohydrate beverages with or without vitamin C in a
double-blinded fashion using a color code (according to the origi-
nal randomization scheme). The carbohydrate-vitamin C beverage
contained vitamin C at a concentration of 150 mg/l. As in earlier
studies, the carbohydrate beverages, with or without vitamin C,
were supplied by the Gatorade Sports Science Institute (Barring-
ton, Ill., USA) (Nehlsen-Cannarella et al. 1997; Nieman 2000;
Nieman et al. 1997, 1998; 2001b). Each runner ingested 750 ml of
beverage and one 500-mg vitamin C or placebo tablet approxi-
mately 30 min prior to the start of the race (5:30 a.m). During the
race, runners drank approximately 1 l of beverage each hour (60 g
carbohydrate/h). Research assistants were positioned every 5 km
(three aid stations on the 16-km loop) to deliver color-coded bev-
erage bottles, which contained 500 ml fluid (with or without vita-
min C). Runners ingested the fluid from two bottles per hour and
also ate two to three carbohydrate gel packs per hour (each con-
taining 25 g of carbohydrate). Runners agreed to avoid all other
beverages and food before and during the race. The research as-
sistants also recorded heart rates and ratings of perceived exertion
(RPE, 6–20 scale) from each runner every 5 km.
After running 32 km, and then again after crossing the 80-km
race finish line, blood and saliva samples were collected from
subjects within 5 min. Secondary to extreme environmental con-
ditions (see Results), some runners were unable to complete the
race due to fatigue or the 12-h limit (imposed by the research team).
Blood and saliva samples were collected from these runners if they
ran at least 50 km. Subjects were weighed at 32 km and post-race.
A post-race questionnaire completed by each runner verified
compliance to all aspects of the research design by each runner.
Salivary samples
Unstimulated saliva was collected by expectoration into 15-ml
plastic, sterilized vials for 4 min. Participants were urged to pass as
much saliva as possible into the vials during the 4-min timed ses-
sion. The saliva samples were frozen at )0C until analysis. Saliva
volume was measured to the nearest 0.1 ml, and saliva total protein
was quantified using the Coomassie protein assay reagent, a
modification of the Bradford Coomassie dye binding colorimetric
method (Bradford 1976). Salivary IgA was measured by enzyme-
linked immunosorbent assay according to the procedures adapted
from the Hunter Immunology Unit (Royal Newcastle Hospital,
Newcastle, NSW, Australia) (Gleeson et al 1999a, 1999b, 2000).
The data were expressed as concentration of sIgA (lg.ml)1), con-
centration of sIgA relative to total protein concentration (lg.mg)1),
and sIgA secretion rate (lg.min)1). Data on other immune mea-
sures are being published elsewhere (Nieman et al. 2002).
Blood measures and plasma volume
Blood samples were drawn from an antecubital vein with subjects
in the seated position. Samples were centrifuged in sodium heparin
tubes. The plasma was removed and stored at )80C. Plasma
cortisol was assayed using the competitive solid-phase 125I radio-
immunoassay (RIA) technique (Diagnostic Products, Los Angeles,
Calif., USA). Plasma was analyzed spectrophotometrically for
glucose (pre-run, 32 km and post-race). Plasma volume changes
were estimated using the method of Dill and Costill (1974).
Oxidative measurements
Blood samples were immediately centrifuged at 4C. The plasma
was aliquoted into cryotubes and snap frozen in liquid nitrogen.
Samples were stored at )80C until analysis. F2-isoprostane was
analyzed by gas chromatography mass spectrometry (Morrow
2000). Lipid hydroperoxides (ROOH) were measured using a
spectrophotometric kit provided by Caymen Chemicals (Cat. no.
705002).
Statistical analysis
Statistical significance was set at the P<0.05 level, and values ex-
pressed as mean (SE). Vitamin C and placebo groups were com-
pared for subject characteristics and race performance measures
using Student’s t-tests. Salivary measures were analyzed using 2
(vitamin C and placebo groups) x 3 (times of measurement) re-
peated-measures ANOVA. If the group x time interaction P value
was £ 0.05, the change from baseline for 32 km and post-race
values was compared between groups using Student’s t-tests. For
the multiple comparisons across groups, a Bonferroni adjustment
was made, with statistical significance set at P<0.025. Pearson
product-moment correlations were used to test the relationship
between all post-race measures.
Results
Twenty-eight ultramarathoners complied with all as-
pects of the study and completed at least 50 km of the
race. Table 1 lists the subject characteristics for the vi-
tamin C (N=15) and placebo (N=13) groups. The
runners were experienced and committed to regular
training and racing but were well below elite status.
There was no significant difference between the groups
for age, stature, body mass, running and racing experi-
ence, and cardiorespiratory fitness. There was no sig-
nificant difference in pre-race diet with mean energy
intake of 11.2 (0.2) MJ/day, carbohydrate 55.3 (2.8)%
of total energy, fat 29.0 (1.8)% of total energy and vi-
tamin C 147 (24) mg/day.
Table 1 Subject characteristics
[mean (SE)] Characteristic Vitamin C (N=15) Placebo (N=13) P-value
Mean SE Mean SE
Age (years) 49.9 (3.5) 45.2 (2.8) 0.312
Stature (m) 1.73 (0.02) 1.74 (0.02) 0.642
Body mass (kg) 76.8 (2.4) 76.4 (2.8) 0.912
Running experience (years) 14.3 (2.3) 13.7 (2.5) 0.852
Training distance (km Æ week)1) 58.9 (9.7) 70.3 (5.6) 0.321
Ultramarathons raced 21.2 (8.1) 20.3 (6.6) 0.934
_V O2max (ml Æ kg
)1 Æ min)1) 47.2 (1.8) 48.4 (2.3) 0.693
VEmax(l Æ min)1) 134 (6) 137 (6) 0.689
HRmax(beats Æ min
)1) 181 (4) 183 (4) 0.725
RERmax 1.15 (0.02) 1.16 (0.02) 0.841
Environmental conditions were measured four times
during the race. At 6:00 a.m. readingswere 18Cand 90%
relative humidity (rh), at 10:00 a.m. 24C and 60% rh, at
2:00 p.m. 31C and 40% rh, and at 6:00 p.m. 30C and
40% rh. The average heart rates during the race were not
significantly different between the vitamin C and placebo
groups [135 (4) and 136 (5) beats per minute, 75.7 (1.9)%
and 75.2 (2.1)% HRmax respectively]. The vitamin C
group ran a mean of 68.7 (3.3) km in 9.85 (0.36) h, which
was not significantly different from the placebo group
which completed 68.7 (3.5) km in 9.68 (3.5) h. RPE av-
eraged 10.9 (0.3) (‘‘fairly light’’ 6–20 scale) during the first
15 km, and rose to 14.3 (1.2) for the vitamin C group and
15.0 (1.8) for the placebo group at the end of the race.
There was no significant difference in fluid intake between
the two groups. The vitaminC group drank 1.04 (0.08) l/h
while the placebo groupdrank 0.85 (0.06) l/h,with amean
intake of 57 g of carbohydrate per hour for both groups.
The runners also averaged 2.3 (0.16) gel packs or 58 g of
carbohydrate per hour. Modest changes in body mass
[vitamin C 1.88 (0.37) kg, placebo 1.79 (0.24) kg] and
plasma volume [vitamin C 4.02 (0.48)%, placebo 2.74
(0.55)%] were measured but did not differ significantly
between the two groups.
Plasma vitamin C was significantly higher in the vi-
tamin C compared to placebo group pre-race, at 32 km,
and post-race (Table 2). No significant group or inter-
action effects were measured for lipid hydroperoxides
and F2-isoprostane, but both oxidative measures rose
significantly during the ultramarathon race (Table 2).
Post-race lipid hydroperoxides and F2-isoprostane were
positively correlated (r=0.44, P=0.019). F2-isoprostane
tended to be higher in the vitamin C compared to pla-
cebo group across all time points (group effect,
P=0.051) (Table 2). No significant interaction effect
was measured for serum glucose (data not shown). Se-
rum cortisol rose strongly in both groups during the
race, with a slightly greater increase measured in the
vitamin C group (group · time interaction, p=0.034)
(Fig. 1). Post-race serum cortisol was positively corre-
lated with serum vitamin C (r=0.50, P=0.006), but no
other significant correlations were found between serum
vitamin C or oxidative and sIgA parameters.
Table 3 and Figs. 2 and 3 summarize the salivary IgA
data. No significant group or interaction effects were
measured for saliva secretion rate, saliva protein con-
centration, and saliva protein IgA concentration (Ta-
ble 3). The saliva secretion rate (volume of saliva in
4 min) declined in both groups at 32 km and post-race
compared to the pre-race values (Table 3). Saliva pro-
tein concentration did not change significantly from pre-
race values at either 32 km or post-race (Table 3). Sliva
protein IgA concentration decreased 37% and 31%
post-race in the vitamin C and placebo groups, respec-
tively (Table 3). The pattern of change in sIgA concen-
tration did not differ significantly between groups
(P=0.713). Saliva IgA concentration decreased in the
vitamin C and placebo groups at 32 km ()38% and
)47%, respectively) and post-race ()26% and )27%,
respectively) (Fig. 2). The pattern of change in sIgA
secretion rate did not differ significantly between groups
(P=0.705). Saliva IgA secretion rate decreased in the
vitamin C and placebo groups at 32 km ()58% and
)66%, respectively) and post-race ()45% and )40%,
respectively) (Fig. 3).
Discussion
This study measured the influence of vitamin C supple-
mentation (1500 mg/day for 7 days prior to and the day
of the ultramarathon race) compared to placebo on
Table 2 Ascorbic acid and
oxidative measures Parameter Pre-race 32-km Post-race Effect: group
interaction time
Mean SD Mean SD Mean SD
Plasma ascorbic acid (lg/100ll) <0.001
Vitamin C 1.25 (0.11) 2.56 (0.15) 3.21 (0.29) <0.001
Placebo 0.73 (0.10) 1.08 (0.15) 1.28 (0.12) <0.001
Lipid hydroperoxide (lM) 0.921
Vitamin C 31.3 (2.1) 32.1 (2.3) 39.8 (4.4) 0.079
Placebo 36.3 (0.7) 27.0 (3.1) 39.2 (3.6) 0.027
F2-isoprostane (pg/ml) 0.051
Vitamin C 60.4 (8.2) 64.5 (7.0) 75.1 (5.6) 0.864
Placebo 44.8 (2.8) 53.7 (4.0) 62.6 (2.8) 0.003
Fig. 1 Serum cortisol rose in both groups during the race, with a
slightly greater increase measured in the vitamin C group (group ·
time interaction, P=0.034)
oxidative and sIgA changes in carbohydrate-fed runners
during and following an ultramarathon race. Vitamin C
compared to placebo supplementation had no influence
on any of the measured salivary and oxidative parame-
ters in subjects running at approximately 75% HRmax
for 10 h. No significant correlations were found between
post-race plasma vitamin C, oxidative, and sIgA mea-
sures. This is the first study to test the influence of vi-
tamin C supplementation on measures of both oxidative
and sIgA following a competitive race.
Saliva IgA secretion rate, saliva IgA concentration
and saliva protein IgA concentration decreased during
and following the ultramarathon. This is in agreement
with several previous studies that have studied the effects
of endurance exercise on sIgA (Krywkowski et al. 2001;
Müns et al. 1989; Nieman et al. 2001a; Tomasi et al.
1982). The decrease in the saliva values observed after
exercise is dependent on both the duration and intensity
of the exercise, with greater alterations observed fol-
lowing prolonged heavy exertion (Mackinnon and
Hooper 1994; McDowell et al. 1991).
In recent years, researchers have attempted to iden-
tify nutritional countermeasures to exercise-induced
changes in sIgA. Several studies have demonstrated that
carbohydrate supplementation has no significant influ-
ence on sIgA changes following heavy exertion. In a
study of 98 marathon runners, sIgA concentration, sa-
liva protein IgA, and sIgA secretion rates decreased
equally for both carbohydrate- and placebo-supple-
mented groups (Nieman et al. 2001a). The same findings
were reported in a study of carbohydrate-fed female
rowers engaged in 2 h of rowing drills (Nehlsen-Can-
narella et al. 2000). Krzykowski et al. (2001) examined
the effects of glutamine and protein supplementation on
decreases in sIgA. Eleven athletes exercised at 75% of
_V O2max for 2 h on a cycle ergometer on three separate
days. Glutamine, protein, and placebo supplements were
given during and for 2 h after exercise. Supplementation
did not attenuate the exercise-induced decrease in sIgA
values even though plasma glutamine values were
maintained. Additional research is necessary to elucidate
the mechanisms associated with the mucosal immune
system and to identify other possible means for attenu-
ating the decrease in sIgA.
Vitamin C supplementation did not attenuate exer-
cise-induced oxidative stress in the present investigation.
Similar results have been obtained from several recent
studies testing the effectiveness of vitamin C at protect-
ing against exercise-generated ROS (Peters et al. 2001;
Rokitzki et al. 1994; Thompson et al. 2001). This lack of
Table 3 Salivary IgA changes
inresponse to running an
ultramarathon in vitamin C
(N=15) and placebo (N=13)
groups
Parameter Pre-Race 32 km Post-Race Effect: group
interaction time
Saliva volume (ml Æ 4 min)1) 0.515
Vitamin C 1.93 (0.09) 1.18 (0.11) 1.41 (0.08) 0.716
Placebo 1.90 (0.11) 1.01 (0.15) 1.38 (0.16) <0.001
Saliva protein concentration
(mg Æ ml)1)
0.420
Vitamin C 1.25 (0.15) 1.15 (0.12) 1.42 (0.17) 0.918
Placebo 1.32 (0.17) 1.36 (0.18) 1.59 (0.26) 0.175
Saliva protein IgA concentration
(lg Æ mg)1)
0.340
Vitamin C 520 (70.0) 297 (33.0) 330 (49.0) 0.835
Placebo 442 (39.0) 241 (47.0) 307 (68.0) <0.001
Fig. 2 The pattern of change in salivary immunoglobulin A (sIgA)
concentration did not differ significantly between groups
(P=0.713). Saliva IgA concentration decreased in the vitamin C
and placebo groups at 32 km ()38% and )47%, respectively) and
post-race ()26% and )27%, respectively)
Fig. 3 The pattern of change in sIgA secretion rate did not differ
significantly between groups (P=0.705). Saliva IgA secretion rate
decreased in the vitamin C and placebo groups at 32 km ()58%
and )66%, respectively) and post-race ()45% and )40%,
respectively)
attenuation could partially be due to the location of
vitamin C within hydrophilic compartments. Radicals
attacking lipid membranes are primarily scavenged by
vitamin E, which is present in the phospholipid bilayer.
Upon reducing the radical, vitamin E is oxidized into a
weakly reactive tocopherol radical. The tocopherol
radical is then reduced by vitamin C in the hydrophilic
compartments. This final radical reduction acts to re-
plenish vitamin E stores within the cell membrane. Thus,
vitamin E is a much more potent defender against lip-
ophilic radicals, while vitamin C is more effective at
protecting against hydrophilic radicals (Mylonas and
Kouretas 1999). This mechanism could potentially ex-
plain the apparent ineffectiveness of vitamin C at re-
ducing lipid peroxidation by exercise-induced ROS. A
recent study supports the observation that vitamin C is
not effective at reducing lipid peroxidation, regardless of
dose. Fifteen healthy young women who received vita-
min C doses of 30–2500 mg daily had unchanged levels
of plasma and urine F2-isoprostanes (Levine et al. 2001).
Few studies have examined the relationship between
oxidative stress and immunosuppression. However, a
study conducted by Franci et al. (1996) found that
thermally induced oxidative stress negatively affected
lymphocyte function, specifically cell proliferation and
immunoglobulin (Ig) function. It was also observed
that the presence of vitamin E attenuated these immu-
nosuppressive effects, while vitamin C administration
elicited no response. Significantly increased pre-to-post
race F2-isoprostane concentrations demonstrated
exercise-induced oxidative stress in subjects; however, the
current investigation was unable to show that vitamin C
supplementation demonstrated any protective effects
against exercise-induced oxidative stress, nor was it able
to link any oxidative measures to exercise-induced
reductions in sIgA.
Most studies have failed to show an influence of
vitamin C supplements on immune changes following
intense endurance exercise (Krause et al. 2001; Nieman
et al. 1997, 2002; Petersen et al. 2001). In the present
study, we also examined immune cell counts, plasma
concentrations of interleukins IL-6, IL-10, IL-1ra, and
IL-8, mitogen-stimulated lymphocyte proliferation, and
IL-2 and interferon gamma (IFN-c) production
(Nieman et al. 2002). As reported elsewhere, vitamin C
compared to placebo supplementation had no significant
effect on the pattern of change in these immune
parameters following an ultramarathon (Nieman et al.
2002). A study of 12 marathoners, who ran for 2.5 h on
treadmills after receiving either vitamin C or placebo
supplementation, revealed no differences in the pattern
of changes in hormonal and immune values (including
natural killer cell activity, mitogen-stimulated lympho-
cyte proliferation, granulocyte/monocyte phagocytosis
and oxidative burst activity, leukocyte subsets, and IL-6)
(Nieman et al. 1997). Krause et al. (2001) reported no
effects of vitamin C supplementation (2000 mg/day for
1 week) on neutrophil phagocytosis and bactericidal
ability following a competitive biathlon (16 km uphill
cycling and 2 km uphill running). However, that study
did not include a placebo supplement, and subjects were
not randomized to treatment conditions. In another
study, male runners ingested 500 mg vitamin C and
400 mg vitamin E or placebo for 14 days before and
7 days after running downhill for 90 min on treadmills
(Petersen et al. 2001). Despite a substantial elevation in
plasma measures of vitamin C and E, no group differ-
ences were measured for the pattern of change in cyto-
kines and 13 lymphocyte subsets.
The results of this study revealed no correlation be-
tween serum cortisol and post-race sIgA parameters, but
post-race serum cortisol was positively correlated with
serum vitamin C. These findings do not support the hy-
pothesis that vitamin C supplementation attenuates the
exercise-induced increase in cortisol levels. These findings
are in disagreement with the results of a study of 29 ul-
tramarathon runners competing in the Comrades 90-km
race. In that study, post-race serum cortisol measures
were negatively correlatedwith vitaminC, and the pattern
of change in cortisol was significantly lower in the vitamin
C compared to placebo groups (Nieman et al. 2000; Peters
et al. 2001). There are several possible explanations for the
conflicting results. In the Comrades study, subjects were
not randomized to treatment groups, and carbohydrate
intake during the race was not controlled. This is in con-
trast to methods followed in the present study (Nieman
et al. 2000; Peters et al. 2001). Carbohydrate compared to
placebo beverage ingestion has a marked effect on post-
exercise changes in stress hormones, including cortisol,
and immunity. (Nehlsen-Cannarella et al. 1997; Nieman
2000; Nieman et al. 1998, 2001b).
In conclusion, our data indicate that vitamin C
supplementation does not serve as a countermeasure to
post-race oxidative and sIgA changes in carbohydrate-
fed ultramarathon runners. The decreases in sIgA
concentration, secretion rate, and sIgA protein con-
centration following heavy exertion appear to be
stereotypical and not affected by vitamin C supplemen-
tation. Statistical correlations suggest that oxidative
stress has little influence on the mucosal immune
changes that take place during or following a competi-
tive ultramarathon race. Despite vitamin C supplemen-
tation, the decrease in sIgA in this study was large,
suggesting that continued research is necessary for other
potential countermeasures that may have significant
implications for ultra-athletes.
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